{"entity":{"type":"insider","cik":"0001730866","url":"/insider/0001730866","json_url":"/insider/0001730866.json","name":"Calhoun Lesley Ann","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":11,"first":"2018-02-13","last":"2024-06-07","span_basis":"filed_date"},"name_variants":[{"name":"Calhoun Lesley Ann","source":"filing","n_filings":11,"first_seen":"2018-02-13","last_seen":"2024-06-07"}],"transactions":[{"id":2826572,"accession":"0000950170-24-070875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-070875","line_url":"/filing/0000950170-24-070875#line-2","is_derivative":false,"issuer_cik":"0001730866","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001730866","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.2078,"price_display":"7.21","price_state":"stated","total_value":36039.0,"total_display":"36,039.00","total_whole":"36,039","shares_owned_after":6250.0,"shares_owned_after_display":"6,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":3276276,"accession":"0000899243-20-014410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-014410","line_url":"/filing/0000899243-20-014410#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":70.1,"price_display":"70.10","price_state":"stated","total_value":189270.0,"total_display":"189,270.00","total_whole":"189,270","shares_owned_after":154.0,"shares_owned_after_display":"154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-28","scope":"insider"},{"id":2952827,"accession":"0000899243-20-013683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-013683","line_url":"/filing/0000899243-20-013683#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23330.0,"shares_display":"23,330","price_per_share":74.67,"price_display":"74.67","price_state":"stated","total_value":1742051.1,"total_display":"1,742,051.10","total_whole":"1,742,051","shares_owned_after":154.0,"shares_owned_after_display":"154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2541589,"accession":"0000899243-20-013018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-013018","line_url":"/filing/0000899243-20-013018#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2992.0,"shares_display":"2,992","price_per_share":78.3798,"price_display":"78.38","price_state":"stated","total_value":234512.3616,"total_display":"234,512.36","total_whole":"234,512","shares_owned_after":154.0,"shares_owned_after_display":"154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider"},{"id":2541587,"accession":"0000899243-20-013018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-013018","line_url":"/filing/0000899243-20-013018#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":381.0,"shares_display":"381","price_per_share":77.0492,"price_display":"77.05","price_state":"stated","total_value":29355.7452,"total_display":"29,355.75","total_whole":"29,356","shares_owned_after":3146.0,"shares_owned_after_display":"3,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"},{"id":7967163,"accession":"0000899243-19-023567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-023567","line_url":"/filing/0000899243-19-023567#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2765.0,"shares_display":"2,765","price_per_share":54.3567,"price_display":"54.36","price_state":"stated","total_value":150296.2755,"total_display":"150,296.28","total_whole":"150,296","shares_owned_after":887.0,"shares_owned_after_display":"887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-13","scope":"insider"},{"id":8339712,"accession":"0000899243-19-003661","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-003661","line_url":"/filing/0000899243-19-003661#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":354.0,"shares_display":"354","price_per_share":50.453,"price_display":"50.45","price_state":"stated","total_value":17860.362,"total_display":"17,860.36","total_whole":"17,860","shares_owned_after":1032.0,"shares_owned_after_display":"1,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider"},{"id":6593518,"accession":"0000899243-18-022840","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-18-022840","line_url":"/filing/0000899243-18-022840#line-6","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":49.188,"price_display":"49.19","price_state":"stated","total_value":14756.4,"total_display":"14,756.40","total_whole":"14,756","shares_owned_after":838.0,"shares_owned_after_display":"838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-20","scope":"insider"},{"id":6593516,"accession":"0000899243-18-022840","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-18-022840","line_url":"/filing/0000899243-18-022840","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1704.0,"shares_display":"1,704","price_per_share":50.008172535211266,"price_display":"50.01","price_state":"stated","total_value":85213.926,"total_display":"85,213.93","total_whole":"85,214","shares_owned_after":1138.0,"shares_owned_after_display":"1,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-20","scope":"insider","n_lines":2},{"id":8543552,"accession":"0000899243-19-003657","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-003657","line_url":"/filing/0000899243-19-003657#line-4","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258.0,"shares_display":"258","price_per_share":43.52,"price_display":"43.52","price_state":"stated","total_value":11228.16,"total_display":"11,228.16","total_whole":"11,228","shares_owned_after":1032.0,"shares_owned_after_display":"1,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2019-02-14","scope":"insider"},{"id":6647018,"accession":"0000899243-18-019717","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-019717","line_url":"/filing/0000899243-18-019717#line-4","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2295.0,"shares_display":"2,295","price_per_share":44.274,"price_display":"44.27","price_state":"stated","total_value":101608.83,"total_display":"101,608.83","total_whole":"101,609","shares_owned_after":388.0,"shares_owned_after_display":"388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-09","filed_date":"2018-07-10","scope":"insider"},{"id":6647012,"accession":"0000899243-18-019717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-019717","line_url":"/filing/0000899243-18-019717#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":44.005,"price_display":"44.00","price_state":"stated","total_value":44005.0,"total_display":"44,005.00","total_whole":"44,005","shares_owned_after":388.0,"shares_owned_after_display":"388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-10","scope":"insider"},{"id":8543548,"accession":"0000899243-19-003657","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-003657","line_url":"/filing/0000899243-19-003657#line-3","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187.0,"shares_display":"187","price_per_share":44.88,"price_display":"44.88","price_state":"stated","total_value":8392.56,"total_display":"8,392.56","total_whole":"8,393","shares_owned_after":1290.0,"shares_owned_after_display":"1,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-03","filed_date":"2019-02-14","scope":"insider"},{"id":8543544,"accession":"0000899243-19-003657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-003657","line_url":"/filing/0000899243-19-003657#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510.0,"shares_display":"510","price_per_share":54.68,"price_display":"54.68","price_state":"stated","total_value":27886.8,"total_display":"27,886.80","total_whole":"27,887","shares_owned_after":1477.0,"shares_owned_after_display":"1,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2019-02-14","scope":"insider"},{"id":6216537,"accession":"0000899243-18-006362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-006362","line_url":"/filing/0000899243-18-006362#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99.0,"shares_display":"99","price_per_share":60.35,"price_display":"60.35","price_state":"stated","total_value":5974.65,"total_display":"5,974.65","total_whole":"5,975","shares_owned_after":388.0,"shares_owned_after_display":"388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-05","scope":"insider"},{"id":5977642,"accession":"0000899243-18-003749","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-003749","line_url":"/filing/0000899243-18-003749#line-3","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":113.0,"shares_display":"113","price_per_share":30.3,"price_display":"30.30","price_state":"stated","total_value":3423.9,"total_display":"3,423.90","total_whole":"3,424","shares_owned_after":187.0,"shares_owned_after_display":"187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2018-02-13","scope":"insider"},{"id":5977635,"accession":"0000899243-18-003749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-003749","line_url":"/filing/0000899243-18-003749#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001730866","owner_name":"Calhoun Lesley Ann","owner_display_name":"Calhoun Lesley Ann","owner_url":"/insider/0001730866","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1552.0,"shares_display":"1,552","price_per_share":27.23,"price_display":"27.23","price_state":"stated","total_value":42260.96,"total_display":"42,260.96","total_whole":"42,261","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2018-02-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819133","name":"Tango Therapeutics, Inc.","url":"/issuer/0001819133","role":"Director","n_filings":1,"first_seen":"2024-06-07","last_seen":"2024-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Officer","n_filings":10,"first_seen":"2018-02-13","last_seen":"2020-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001730866","retrieved_at":"2026-08-23T17:41:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}